Program
comtifator
Also written as “BMS-986419”, “BMS-986419 DR Capsule” and “BMS-986419 IR Tablet”.
Its studies are led by Bristol-Myers Squibb.
Furthest: phase 1, since Apr 27, 20234 company-led studies, 0 open or running
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Bristol-Myers Squibb | 40 open or running | phase 1since Apr 27, 2023 | Apr 27, 2023 | none ahead |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Apr 27, 2023First study: phase 1 study in Healthy VolunteersFirst studyNCT05847439 · 8 enrolled · United States
- Jun 27, 2023Phase 1 study in Healthy VolunteersNCT05932277 · 22 enrolled · United States
- Jul 20, 2023Phase 1 study in Healthy VolunteersNCT05963932 · 60 enrolled · United States
- Feb 21, 2025Phase 1 study in Healthy VolunteersNCT06846866 · 74 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06846866Healthy Volunteers · United States | 1 | Completed | Oct 21, 2025 | 74 |
| NCT05963932Healthy Volunteers · United States | 1 | Completed | Oct 17, 2023 | 60 |
| NCT05932277Healthy Volunteers · United States | 1 | Completed | Sep 13, 2023 | 22 |
| NCT05847439Healthy Volunteers · United States | 1 | Completed | Jul 5, 2023 | 8 |
How it is read
Names in the registry
- “BMS-986419”, 2 entries
- “BMS-986419 DR Capsule”, 1 entry
- “BMS-986419 IR Tablet”, 1 entry
- “[14C]BMS-986419”, 1 entry
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.